ICVAX as a HIV Therapeutic DNA Vaccine

Clinical trial NCT06253533 · COMPLETED

Trial details

NCT number: NCT06253533
Sponsor: Immuno Cure Holding (HK) Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Human Immunodeficiency Virus I Infection

Start date: 2023-02-14
Primary completion: 2024-09-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.